Orgenesis (ORGS) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ORGS Stock Alerts $0.50 -0.01 (-1.96%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOrgenesis secures $2.3 million investment and strategic partnershipinvesting.com - April 17 at 11:58 AMOrgenesis Inc.: Orgenesis Provides Year End Business Updatefinanznachrichten.de - April 17 at 9:28 AMOrgenesis Provides Year End Business Updateglobenewswire.com - April 15 at 5:07 PMGermfree partners with Orgenesis to enhance CGT productioninvesting.com - April 11 at 7:22 PMGermfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibilityglobenewswire.com - April 10 at 12:00 PMVered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conferenceglobenewswire.com - March 18 at 8:30 AMOrgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomesglobenewswire.com - March 13 at 8:30 AMOrgenesis Inc. Announces $2.3 Million Private Placementglobenewswire.com - March 4 at 8:30 AMOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturingglobenewswire.com - February 29 at 8:30 AMOrgenesis Inc. (ORGS)finance.yahoo.com - February 23 at 2:21 PMOrgenesis Inc ORGSmorningstar.com - February 22 at 9:04 PMEXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinicmsn.com - January 31 at 10:11 AMOrgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinicfinance.yahoo.com - January 31 at 10:11 AMOrgenesis Inc. (ORGS) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 8 at 2:42 PMAnalysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven Soonfinance.yahoo.com - November 22 at 7:49 AMOrgenesis Inc.: Orgenesis Provides Business Update for the Third Quarter of 2023finanznachrichten.de - November 15 at 8:44 PMOrgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMfinance.yahoo.com - November 14 at 9:23 AMOrgenesis Provides Business Update for the Third Quarter of 2023finance.yahoo.com - November 13 at 5:46 PMOrgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offeringfinance.yahoo.com - November 8 at 10:26 AM6 Secrets Of Organizations That Successfully Adapt To Changeforbes.com - November 5 at 8:34 PMOrgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Fundingfinance.yahoo.com - November 2 at 8:08 AMOrgenesis Inc.: Orgenesis Announces Withdrawal of Proposed Public Offeringfinanznachrichten.de - October 31 at 8:11 AMOrgenesis Announces Withdrawal of Proposed Public Offeringfinance.yahoo.com - October 30 at 11:20 PMOrgenesis Announces Proposed Underwritten Public Offeringfinance.yahoo.com - October 30 at 6:20 PMCGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United Statesstockhouse.com - September 21 at 9:35 AMCGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United Statesfinance.yahoo.com - September 21 at 9:35 AMOrgenesis Inc (ORGS): A Deep Dive into Its Performance Potentialfinance.yahoo.com - August 28 at 1:02 PMIs Orgenesis (ORGS) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trapfinance.yahoo.com - August 28 at 1:02 PMOrgenesis (ORGS): A Value Trap in Disguise?finance.yahoo.com - August 24 at 6:26 AMHow to help Maui fire victims from afar: Organizations and efforts underwayabcnews.go.com - August 13 at 4:18 PMOrgenesis Inc.: Orgenesis Provides Business Update for Second Quarter of 2023finanznachrichten.de - August 11 at 12:54 PMOrgenesis Provides Business Update for Second Quarter of 2023finance.yahoo.com - August 11 at 12:54 PMOrgenesis Schedules Second Quarter 2023 Business Update Conference Callfinance.yahoo.com - August 10 at 9:57 AMOrgenesis Inc.: Orgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officerfinanznachrichten.de - July 13 at 5:43 PMOrgenesis Names Maltz Finance Chief as Reithinger Resigns >ORGSmarketwatch.com - July 13 at 12:42 PMOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officerfinance.yahoo.com - July 13 at 12:42 PMOrgenesis Announces Name Change of Morgenesis Business Unit to Octomerafinance.yahoo.com - July 11 at 7:45 AMOrgenesis Inc. (NASDAQ:ORGS) On The Verge Of Breaking Evenfinance.yahoo.com - June 15 at 7:51 AMOrgenesis and University of California, Davis Sign Partnership Agreement for Rollout of Cell and Gene Therapy Mobile Processing Units and Labs Throughout Californiafinance.yahoo.com - June 7 at 7:45 AMClaudia Zylberberg Appointed as Independent Board Member of POCare Business Subsidiary of Orgenesisfinance.yahoo.com - May 30 at 10:22 AMOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master's Programbenzinga.com - May 22 at 9:27 AMOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master’s Programfinance.yahoo.com - May 22 at 9:27 AMOrgenesis to Participate in Benchmark’s 3rd Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023finance.yahoo.com - May 19 at 9:05 AMOrgenesis Announces Collaboration Agreement with SCTbio to Expand POCare Sites in the Czech Republic and Enhance Capabilities for the Production of Lentivirus Vectorsfinance.yahoo.com - May 18 at 7:40 AMOrgenesis Provides Business Update for the First Quarter of 2023 and Reports Continued Progress on its POCare Strategyfinance.yahoo.com - May 10 at 5:19 PMOrgenesis Secures an Additional $5 Million Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Service Subsidiaryfinance.yahoo.com - May 10 at 1:24 PMThe Secret To Sustainability For Non-profit Organizationsforbes.com - April 26 at 8:04 PMOrgenesis CEO Vered Caplan Featured in Keynote Series at INTERPHEX Conference to Discuss Innovations in Cell & Gene Therapy Manufacturingfinance.yahoo.com - April 25 at 9:17 AMCrowdStrike turns to managed XDR to help orgs navigate the cyber skills gapventurebeat.com - April 22 at 1:47 PMOrgenesis Inc.'s (NASDAQ:ORGS) Share Price Is Matching Sentiment Around Its Revenuesfinance.yahoo.com - April 19 at 6:03 PM Get Orgenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Secret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. ORGS Media Mentions By Week ORGS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGS News Sentiment▼0.210.51▲Average Medical News Sentiment ORGS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGS Articles This Week▼30▲ORGS Articles Average Week Get Orgenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Benitec Biopharma News MIRA Pharmaceuticals News Kiora Pharmaceuticals News Avalo Therapeutics News RedHill Biopharma News JanOne News Cocrystal Pharma News Tonix Pharmaceuticals News Imunon News NanoViricides News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm PressThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.